😕Leila is a monoclonal antibody treatment designed to reduce pain in dogs by targeting specific neurotransmitters in the body.
🐶Approximately 2% of dogs may experience adverse reactions to Leila due to their immune system recognizing it as a foreign protein.
🚫⚖️Leila may not be suitable for dogs with concurrent neurological diseases or those who require early-stage arthritis treatment.
⚠️Common side effects of Leila include wobbliness, slow reflexes, and balance issues, which should be monitored carefully.
💡It is crucial for pet owners and veterinarians to report any suspected adverse reactions to Leila for further evaluation.